Challenges in testing of dosing accuracy according to IEC 60601-2-24 and AAMI TIR-101

Discover the precision of Sartorius Cubis^® II balances in ensuring accurate dosing rates for infusion pumps. This comprehensive study, created in collaboration with B. Braun AG, delves into the challenges of meeting stringent IEC and AAMI standards, analyzing potential sources of error, and providing actionable insights for optimal pump performance testing. Learn how advanced features like the monolithic weighing system and built-in ionizers contribute to reliable measurements, making Cubis^® II balances an essential tool for medical device quality assurance.

Fill out the details below

I consent to Sartorius AG contacting me by electronic mail (e.g. email) or telephone to provide me with personalized information, including invitations to trade shows and other events, newsletters and information and offers related to products and services in the areas of life science research, biopharmaceutical and applied industry of Sartorius AG and its affiliated companies, and to carry out customer satisfactions surveys. This also covers the processing of my personal data provided above for these purposes, including profile building to better tailor the communication to my personal interests based on my previous and predicted choices.

You can withdraw your consent at any time with effect for the future. This does not affect the lawfulness of the processing up to the time of withdrawal.

Further information on the processing of personal data can be found in the Sartorius Privacy Notice.

By submitting your information, you agree that Sartorius may collect and further process your personal data in accordance with its Privacy Policy.

You may object to receiving further information at any time.

For information on how The Analytical Scientist will treat your personal information please view the privacy notice here.

You have been directed to this site by Enterprise Guide. For more details on our information practices, please see our Privacy Policy, and by accessing this content you agree to our Terms of Use. You can unsubscribe at any time.